1. Bream, J.B., Lauener, H., Picard, C.W., Scholtysik, G., Waite, T.G. (1975): Substituted phenylacetylguanidines: a new class of antihypertensive agents. Arzneimittel-Forsch.25, 1477–1482.
2. Jäättelä, A. (1976): Clinical efficacy of BS 100–141 in essential hypertension. Europ. J. clin. Pharmac.10, 69–72.
3. Jerie, P. & Lasance, A. (1981): Guanfacine in the treatment of hypertension: Two years’ experience with low dose monotherapy. Int. J. clin. Pharmac, Ther. Tox.19, 279–287.
4. Kiechel, J.R. (1980): Pharmacokinetics and metabolism of guanfacine: a review. Brit. J. clin. Pharmac.10, 25S-32S.
5. Kirch, W. and Dister, A. (1978): Antihypertensive effect of N-amidino-2-(2.6-dichlorophenyl)acetamide hydrochloride: a double-blind cross-over trial versus clonidine. Int. J. clin. Pharmac.16, 132–135.